Century Therapeutics, Inc. (IPSC) vs Palisade Bio, Inc. (PALI)
- Century Therapeutics, Inc. IPSC 1.37 −8.67%
- Palisade Bio, Inc. PALI 1.41 −8.44%
Century Therapeutics, Inc. and Palisade Bio, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Palisade Bio, Inc. are of similar size ($271.6M and $268.4M). Century Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against 5,492.6%. Century Therapeutics, Inc. has the higher net margin (0.00% vs −4,230.6%) and the lower return on invested capital (−64.9% vs 0.00%). Across the 16 metrics below, Century Therapeutics, Inc. leads on 10 and Palisade Bio, Inc. on 6.
Valuation
Profitability
| Metric | IPSC | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.63% | 65.16% |
| Operating margin | 0.00% | (4,681.99%) | 0.00% |
| Net margin | 0.00% | (4,230.60%) | 0.00% |
| Free cash flow margin | 0.00% | (2,409.27%) | 0.00% |
| Return on equity | (49.65%) | (51.37%) | (56.36%) |
| Return on assets | (38.41%) | (47.68%) | (48.04%) |
| Return on invested capital | (64.92%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack